Benign Prostate Hyperplasia Diagnostic Tests: Introduction
- Benign prostate hyperplasia, also called prostate enlargement disorder, is a medical condition in males that progresses with age. The condition is characterized by the narrowing of male ureters, and blockage of normal flow of urine out of the bladder. It also causes several urinary tract disorders, and kidney and bladder disorders.
Read Report Overview -
https://www.transparencymarketresearch.com/benign-prostate-hyperplasia-diagnostic-tests-market.html
- The enlarged prostate creates pressure on the urethra, leading to narrowing down of the urethra and results in urine retention in the bladder. BPH is a non-cancerous medical condition, which means it is treatable.
- Common symptoms of BPH includes frequent or urgent need to urinate, increased frequency of urination, improper flow of urine, dribbling at the end of urination, and inability to empty the bladder fully.
- Exact causes of BPH are not yet clear; however, the chances of developing BPH increases with age. Hormonal changes are also thought to play a key role in developing BPH. The person with family history of BPH, obesity, and erectile dysfunction are at increased risk of contracting BPH.
- Diagnosis of BPH is carried out by various tests, which includes urine tests, blood tests, imaging tests, and cystoscopy tests.
Request Brochure of Report -
https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=79045
Benign Prostate Hyperplasia Diagnostic Tests Market: Key Drivers
- High prevalence and rise in incidence of benign prostate hyperplasia, and rapidly growing aging population across the globe are key factors driving the benign prostate hyperplasia diagnostic tests market
- The prevalence rate of BPH increases with age, from 8% in people aged over 40 years to 60% in people over 90
- Also, according to world population prospects, it is estimated that around 9% of global population is over the age of 65 years, and by the end of 2050, the number would increase to 1 in 6 people, accounting for 16% of global population.
- Technological advancements in the diagnosis of BPH, new test developments, and rise in demand for BPH etc. are factors estimated to propel growth of the market during the forecast period.
Cystoscopy Segment to be Highly Attractive
- In terms of tests, the global benign prostate hyperplasia diagnostics tests market can be segmented into blood tests, urine tests, scan tests, biopsy tests, and cystoscopy. The cystoscopy segment is projected to dominate the global market during the forecast period.
- Cystoscopy involves insertion of a thin flexible tube with camera mounted on the tip through the urethra to examine the urethra and bladder for any abnormalities.
- Extensive applications of cystoscopy tests in the diagnosis of different types of urological disorders, perfect diagnosis, and the fact that it is a minimally invasive diagnostic test are factors likely to represent potential business development opportunity for new entrants planning to enter this market.
Request for Custom Research -
https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=79045
Diagnostic Laboratories to Dominate the Market
- Based on end-user, the global benign prostate hyperplasia diagnostics tests market can be classified into hospitals, diagnostic laboratories, and academic and research institutes. The diagnostic laboratories segment is projected to dominate the global market during the forecast period.
- Presence of a large number of diagnostic laboratories, easy availability and accessibility of tests at these centers, and low cost are major factors that are likely to drive the diagnostic laboratories segment in the near future.
- Rapidly growing number of diagnostic laboratories in emerging economies such as South Korea, India, China, and Brazil, and foreign direct investment in diagnostic laboratories represent potential opportunity in the segment during the forecast period.
Asia Pacific Benign Prostate Hyperplasia Diagnostics Market to Expand Rapidly
- In terms of region, the global benign prostate hyperplasia diagnostics market can be split into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
- North America is likely to dominate the benign prostate hyperplasia diagnostics global market during the forecast period. High prevalence of BPH and rise in geriatric population are key factors that are expected to boost the market in the region during the forecast period.
- The benign prostate hyperplasia diagnostics market in Asia Pacific is anticipated to expand at a notable CAGR during the forecast period. Rapid expansion of the market in the region can be ascribed to a rise in incidence rate of BPH in densely populated countries, such as India and China, and improvement of healthcare infrastructure in the region.
- Significant expansion of the healthcare industry, easy access to healthcare facilities, and increase in investments in healthcare by leading players in Asia Pacific are expected to fuel the market in the region in the near future
Pre Book Benign Prostate Hyperplasia Diagnostics Tests Market Report at
https://www.transparencymarketresearch.com/checkout.php?rep_id=79045<ype=S
Key Players Operating in Global Benign Prostate Hyperplasia Diagnostics Tests Market
The global benign prostate hyperplasia diagnostics tests market is fragmented, with a large number of global players holding majority share. Prominent players operating in the global benign prostate hyperplasia diagnostic tests market include:
- Laboratory Corporation of America Holdings
- Olympus Corporation
- Stryker Corporation
- R. Bard, Inc. (Becton Dickinson and Company)
- Boston Scientific Corporation
- Eurolyser Diagnostica GmbH
- Eurofins Scientific
- Vivomed Ltd.
More Trending Reports by Transparency Market Research –
Transcatheter Embolization and Occlusion Devices Market:
Autoimmune Disease Diagnostics Market:
About Us
Transparency Market Research is a global market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for several decision makers. Our experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.
Our data repository is continuously updated and revised by a team of research experts so that it always reflects latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Contact
Transparency Market Research,
90 State Street, Suite 700,
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
